Table 1.
Patient and treatment characteristics
| Characteristic | n (%) |
| No. of patients | 21 |
| Gender | |
| Female | 10 (47.6) |
| Male | 11 (58.8) |
| Comorbidity | |
| Emphysema | 5 (23.8) |
| Pulmonary insufficiency | 6 (28.6) |
| Coronary artery disease | 4 (19) |
| Cardiac insufficiency | 5 (23.8) |
| Hypoproteinemia | 1 (4.8) |
| Concomitant CBD stones | 16 (76.2) |
| Symptoms | |
| Obstructive jaundice | 11 (52.4) |
| Fever | 6 (28.6) |
| Abdominal pain | 4 (19) |
| Success rate | 20 (95.2) |
| No. of IHS | 36 |
| Diameter of largest IHS | |
| 5-10 mm | 17 (47.2) |
| 10-15 mm | 19 (52.8) |
| No. of CBD stones | 22 |
| Diameter of Largest CBD stones | |
| 5-10 mm | 4 (18.2) |
| 10-15 mm | 5 (22.7) |
| 15-20 mm | 8 (36.4) |
| 20-25 mm | 4 (18.2) |
| 25-28 mm | 1 (4.5) |
| Total No. of stones | 58 |
| Types of stones | |
| Cholesterol stone | 27 (45.7) |
| Mixed stone | 25 (43.1) |
| Bilirubin stone | 6 (10.3) |
IHS: Intrahepatic bile duct stones; CBD: Common bile duct.